Home Antibody All anti-FLT4 antibodies
Anti-FLT4 GAT Antibody Polyclonal
Generated by Genomic Immunization
Also for FLT4 (NM_182925)
|DNA immunization. This antibody is specific for the Middle Region of the target protein.|
||WB: 1:5000-1:20000; ELISA: 1:100-1:2000; IHC: 1:10-1:2000; IHC-P 1:250-1:2000
|20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0|
|The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
|This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT
|Homo sapiens fms-related tyrosine kinase 4 (FLT4), transcript variant 1|
|FLT41; LMPH1A; PCL; VEGFR3|
|Vascular endothelial growth factors (VEGFs) are a family of closely related growth factors having a conserved pattern of eight cysteine esidues and sharing common VEGF receptors. VEGFs stimulate the proliferation of endothelial cells, induce angiogenesis, and increase vascular permeability in both large and small vessels. The mitogenic activity of VEGFs appears to be mediated by specific VEGF receptors. VEGF Receptor 3 is one of the five receptor tyrosine kinases (RTKs) (VEGF Receptor 1/Flt1, VEGF Receptor 2/KDR/Flk1, VEGF Receptor 3/Flt4, tie1 and tek/tie2) whose expression is almost exclusively restricted to endothelial cells.|
Cytokine-cytokine receptor interaction
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.